(Q50920564)

25 March 2018

title

Effect of lamotrigine on depressive symptoms in adult patients with epilepsy. (English)

1 reference

25 March 2018

1 reference

1

Alan B Ettinger

1 reference

25 March 2018

author name string

Robert P Kustra

series ordinal

2

1 reference

25 March 2018

Anne E Hammer

series ordinal

3

1 reference

25 March 2018

publication date

27 October 2006

1 reference

25 March 2018

published in

Epilepsy Behavior

1 reference

25 March 2018

volume

10

1 reference

25 March 2018

issue

1

1 reference

25 March 2018

page(s)

148-154

1 reference

25 March 2018

Depression in epilepsy: etiology, phenomenology, and treatment

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

Symptoms of depression and anxiety in pediatric epilepsy patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

The presence and clinical implications of depression in a community population of adults with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

Diagnosis and treatment of mood disorders in persons with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

Depression and comorbidity in community-based patients with epilepsy or asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

Depression in epilepsy: a common but often unrecognized comorbid malady

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

Optimizing health outcomes in active epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

The influence of comorbid depression on seizure severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

Behavioural effects of the newer antiepileptic drugs: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

Antiepileptic drugs and the regulation of mood and quality of life (QOL): the evidence from epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

Improved mood states with lamotrigine in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

Improvement in depression associated with partial epilepsy in patients treated with lamotrigine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

Lamotrigine Monotherapy Improves Depressive Symptoms in Epilepsy: A Double-Blind Comparison with Valproate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

Lamotrigine: a review of its use in bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

Lamotrigine augmentation strategy for patients with treatment-resistant depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

Sustained remission with lamotrigine augmentation or monotherapy in female resistant depressives with mixed cyclothymic-dysthymic temperament

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

A beneficial effect on mood in partial epilepsy patients treated with gabapentin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

Outcomes of add-on treatment with lamotrigine in partial epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

Affect and mood in epilepsy: an overview with a focus on depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

inferred from DOI database lookup

7 January 2021

based on heuristic

Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.09.008

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEBEH.2006.09.008

1 reference

25 March 2018

1 reference

25 March 2018